Literature DB >> 16061563

In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.

N Sylvius1, Z T Bilinska, J P Veinot, A Fidzianska, P M Bolongo, S Poon, P McKeown, R A Davies, K-L Chan, A S L Tang, S Dyack, J Grzybowski, W Ruzyllo, H McBride, F Tesson.   

Abstract

CONTEXT: Lamin A/C (LMNA) gene variations have been reported in more than one third of genotyped families with dilated cardiomyopathy (DCM). However, the relationship between LMNA mutation and the development of DCM is poorly understood. METHODS AND
RESULTS: We found that end stage DCM patients carrying LMNA mutations displayed either dramatic ultrastructural changes of the cardiomyocyte nucleus (D192G) or nonspecific changes (R541S). Overexpression of the D192G lamin C dramatically increased the size of intranuclear speckles and reduced their number. This phenotype was only partially reversed by coexpression of the D192G and wild type lamin C. Moreover, the D192G mutation precludes insertion of lamin C into the nuclear envelope when co-transfected with the D192G lamin A. By contrast, the R541S phenotype was entirely reversed by coexpression of the R541S and wild type lamin C. As lamin speckle size is known to be correlated with regulation of transcription, we assessed the SUMO1 distribution pattern in the presence of mutated lamin C and showed that D192G lamin C expression totally disrupts the SUMO1 pattern.
CONCLUSION: Our in vivo and in vitro results question the relationship of causality between LMNA mutations and the development of heart failure in some DCM patients and therefore, the reliability of genetic counselling. However, LMNA mutations producing speckles result not only in nuclear envelope structural damage, but may also lead to the dysregulation of cellular functions controlled by sumoylation, such as transcription, chromosome organisation, and nuclear trafficking.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061563      PMCID: PMC1736117          DOI: 10.1136/jmg.2004.023283

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  37 in total

1.  Epidemiology of desmin and cardiac actin gene mutations in a european population of dilated cardiomyopathy.

Authors:  F Tesson; N Sylvius; A Pilotto; L Dubosq-Bidot; M Peuchmaurd; C Bouchier; A Benaiche; L Mangin; P Charron; A Gavazzi; L Tavazzi; E Arbustini; M Komajda
Journal:  Eur Heart J       Date:  2000-11       Impact factor: 29.983

2.  Familial dilated cardiomyopathy: clinical features in French families.

Authors:  L Mangin; P Charron; F Tesson; A Mallet; O Dubourg; M Desnos; A Benaïsche; C Gayet; P Gibelin; J M Davy; J Bonnet; D Sidi; K Schwartz; M Komajda
Journal:  Eur J Heart Fail       Date:  1999-12       Impact factor: 15.534

3.  A missense mutation in the exon 8 of lamin A/C gene in a Japanese case of autosomal dominant limb-girdle muscular dystrophy and cardiac conduction block.

Authors:  T Kitaguchi; S Matsubara; M Sato; K Miyamoto; S Hirai; K Schwartz; G Bonne
Journal:  Neuromuscul Disord       Date:  2001-09       Impact factor: 4.296

4.  A new locus for autosomal dominant dilated cardiomyopathy identified on chromosome 6q12-q16.

Authors:  N Sylvius; F Tesson; C Gayet; P Charron; A Bénaïche; M Peuchmaurd; L Duboscq-Bidot; J Feingold; J S Beckmann; C Bouchier; M Komajda
Journal:  Am J Hum Genet       Date:  2000-11-20       Impact factor: 11.025

5.  Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3.

Authors:  H Saitoh; J Hinchey
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

6.  Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy.

Authors:  W H Raharjo; P Enarson; T Sullivan; C L Stewart; B Burke
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

7.  Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy.

Authors:  C Ostlund; G Bonne; K Schwartz; H J Worman
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

8.  Both emerin and lamin C depend on lamin A for localization at the nuclear envelope.

Authors:  A Vaughan; M Alvarez-Reyes; J M Bridger; J L Broers; F C Ramaekers; M Wehnert; G E Morris; C J Hutchison
Journal:  J Cell Sci       Date:  2001-07       Impact factor: 5.285

9.  Distinct changes in intranuclear lamin A/C organization during myoblast differentiation.

Authors:  B Muralikrishna; J Dhawan; N Rangaraj; V K Parnaik
Journal:  J Cell Sci       Date:  2001-11       Impact factor: 5.285

10.  Ultrastructural abnormality of sarcolemmal nuclei in Emery-Dreifuss muscular dystrophy (EDMD).

Authors:  A Fidziańska; D Toniolo; I Hausmanowa-Petrusewicz
Journal:  J Neurol Sci       Date:  1998-07-15       Impact factor: 3.181

View more
  38 in total

1.  Left ventricular noncompaction in a family with lamin A/C gene mutation.

Authors:  John J Parent; Jeffrey A Towbin; John L Jefferies
Journal:  Tex Heart Inst J       Date:  2015-02-01

Review 2.  Update 2011: clinical and genetic issues in familial dilated cardiomyopathy.

Authors:  Ray E Hershberger; Jill D Siegfried
Journal:  J Am Coll Cardiol       Date:  2011-04-19       Impact factor: 24.094

3.  Sudden cardiac death in a patient with lamin A/C mutation in the absence of dilated cardiomyopathy or conduction disease.

Authors:  Philipp Ehlermann; Stephanie Lehrke; Theano Papavassiliu; Benjamin Meder; Martin Borggrefe; Hugo A Katus; Rainer Schimpf
Journal:  Clin Res Cardiol       Date:  2011-02-16       Impact factor: 5.460

Review 4.  SUMO proteomics to decipher the SUMO-modified proteome regulated by various diseases.

Authors:  Wei Yang; Wulf Paschen
Journal:  Proteomics       Date:  2014-10-28       Impact factor: 3.984

5.  Biomechanical defects and rescue of cardiomyocytes expressing pathologic nuclear lamins.

Authors:  Erik Laurini; Valentina Martinelli; Thomas Lanzicher; Luca Puzzi; Daniele Borin; Suet Nee Chen; Carlin S Long; Patrice Lee; Luisa Mestroni; Matthew R G Taylor; Orfeo Sbaizero; Sabrina Pricl
Journal:  Cardiovasc Res       Date:  2018-05-01       Impact factor: 10.787

Review 6.  Genetics of dilated cardiomyopathy: practical implications for heart failure management.

Authors:  Andrew N Rosenbaum; Katherine E Agre; Naveen L Pereira
Journal:  Nat Rev Cardiol       Date:  2019-10-11       Impact factor: 32.419

7.  Skin deep: what can the study of dermal fibroblasts teach us about dilated cardiomyopathy?

Authors:  Brian C Jensen
Journal:  J Mol Cell Cardiol       Date:  2009-12-11       Impact factor: 5.000

8.  Nesprin-1 mutations in human and murine cardiomyopathy.

Authors:  Megan J Puckelwartz; Eric J Kessler; Gene Kim; Megan M Dewitt; Yuan Zhang; Judy U Earley; Frederic F S Depreux; James Holaska; Stephanie K Mewborn; Peter Pytel; Elizabeth M McNally
Journal:  J Mol Cell Cardiol       Date:  2009-11-24       Impact factor: 5.000

9.  Cytoplasmic localization of PML particles in laminopathies.

Authors:  F Houben; W H De Vos; I P C Krapels; M Coorens; G J J Kierkels; M A F Kamps; V L R M Verstraeten; C L M Marcelis; A van den Wijngaard; F C S Ramaekers; J L V Broers
Journal:  Histochem Cell Biol       Date:  2012-08-25       Impact factor: 4.304

10.  A comparative study of Drosophila and human A-type lamins.

Authors:  Sandra R Schulze; Beatrice Curio-Penny; Sean Speese; George Dialynas; Diane E Cryderman; Caitrin W McDonough; Demet Nalbant; Melissa Petersen; Vivian Budnik; Pamela K Geyer; Lori L Wallrath
Journal:  PLoS One       Date:  2009-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.